See What HealthDay Can Do For You
Contact Us

Increased Insulin Resistance in Rheumatoid Arthritis

Higher levels of insulin resistance not linked to increased atherosclerosis risk in RA patients

THURSDAY, Dec. 11, 2014 (HealthDay News) -- Patients with rheumatoid arthritis (RA) have elevated insulin resistance (IR), but this is not associated with increased atherosclerosis risk, according to a study published online Dec. 10 in Arthritis & Rheumatology.

Jon T. Giles, M.D., M.P.H., from Columbia University in New York City, and colleagues compared IR (estimated using the homeostatic model [HOMA-IR]) between 95 RA patients and 98 demographically-matched non-RA controls.

The researchers found that the average HOMA-IR levels were 31 percent higher in the RA group, regardless of strata of demographic or cardiometabolic risk factors. In the control group, HOMA-IR was strongly and significantly associated with C-reactive protein and interleukin-6, but this association was weaker in the RA group. Higher HOMA-IR correlated with rheumatoid factor positivity in men and women, and with prednisone use in women, among those with RA. Higher HOMA-IR correlated with all assessed subclinical atherosclerosis measures in the control group before adjustment; after adjustment for cardiovascular risk factors, the correlations were attenuated and were no longer statistically significant. Over an average of 3.2 years of follow-up, neither baseline nor average HOMA-IR correlated with change in any measures of atherosclerosis among the RA patients.

"Although IR was higher in RA than in non-RA controls, higher levels may not independently impart additional atherosclerosis risk," the authors write.

Abstract
Full Text (subscription or payment may be required)

Physician's Briefing

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.